8-K Impact 6/10 8-K

REGENEREX PHARMA, INC.

November 16, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Regenerex Pharma filed an 8-K reporting a change in certifying accountant under Item 4.01. The board approved Rosenfield and Company PLLC of Corinth, Texas as the new independent registered public accounting firm, with an engagement letter effective October 26, 2026. The new auditor is preparing the company's past-due Form 10-Q filings to bring it current with reporting obligations.

  • New auditor Rosenfield and Company PLLC appointed effective October 26, 2026.
  • Board finalized approval on October 28, 2026.
  • New firm is preparing past-due Form 10-Q filings.
  • Company is an emerging growth company.
  • Filing does not disclose the predecessor auditor or reason for the change.

Price data unavailable.

An auditor change combined with past-due 10-Q filings signals potential reporting or internal-control issues at the company.

_Not applicable._

The company has past-due Form 10-Q filings, indicating it is not current with SEC reporting obligations.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →